Concepedia

Thomas M. Keck

TM

Statistics

Publications

23

Citations

887

H-Index

18

Active since

2005

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

Rowan University

National Institute of Neurological Disorders and Stroke

Johns Hopkins University

Thomas M. Keck is an author at National Institute on Drug Abuse specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Publications per year

2005–2023

23

Publications

23

Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis

Thomas M. Keck, William S. John, Paul W. Czoty et al. · Journal of Medicinal Chemistry · 2015 · 99 citations · Full text

, , +17

Highly Selective Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R) Antagonists and Partial Agonists Based on Eticlopride and the D<sub>3</sub>R Crystal Structure: New Leads for Opioid Dependence Treatment

Vivek Kumar, Alessandro Bonifazi, Michael P. Ellenberger et al. · Journal of Medicinal Chemistry · 2016 · 89 citations · Full text

, , +17

Interferon Regulatory Factor 3 Is Necessary for Induction of Antiviral Genes during Human Cytomegalovirus Infection

Victor R. DeFilippis, Bridget A. Robinson, Thomas M. Keck et al. · Journal of Virology · 2005 · 75 citations · Full text

, , +16

Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D<sub>3</sub>Receptor

Mayako Michino, Comfort A. Boateng, Prashant Donthamsetti et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

, , +17

High Affinity Dopamine D<sub>3</sub>Receptor (D<sub>3</sub>R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D<sub>3</sub>R Knockout Mice

Comfort A. Boateng, Oluyomi M. Bakare, Jia Zhan et al. · Journal of Medicinal Chemistry · 2015 · 52 citations · Full text

, , +17

1–5 of 23